Nouvelles Eulerpool Biomea Fusion

Biomea Fusion Actualités des actions

Biomea Fusion est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Biomea Fusion.

• 17 décembre ·

  Yahoo
  Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
• 17 décembre ·

  Yahoo
  Biomea Fusion Announces Positive Topline Results from Ongoing Phase II COVALENT-111 Study in Patients with Type 2 Diabetes
• 17 décembre ·

  Yahoo
  Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)
• 9 décembre ·

  Yahoo
  Biomea Fusion Announces Preliminary Data from Ongoing COVALENT-103 Study of Investigational Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia
• 6 décembre ·

  Yahoo
  Biomea Fusion to Host Conference Call to Present initial Clinical Data from Phase I COVALENT-103 Study of BMF-500, a Covalent FLT3 Inhibitor, in Relapsed or Refractory Acute Leukemia
• 18 novembre ·

  Yahoo
  Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management (ATTD-ASIA 2024)
• 13 novembre ·

  Yahoo
  We're A Little Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
• 3 novembre ·

  TipRanks
  Short Report: Archer Aviation shorts at seven-week high
• 1 novembre ·

  Yahoo
  Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
• 31 octobre ·

  TipRanks
  Scotiabank Sticks to Its Buy Rating for Biomea Fusion (BMEA)